References
- Franco S, Hammerschlag MR. Neonatal ocular prophylaxis in the United States: is it still necessary? Exp Rev Anti-Infective Ther. 2023. DOI:10.1080/14787210.2023.2172401
- Frost H, El Feghaly RE, Nedved A, et al. New insights into the treatment of otitis media. Exp Rev Anti-Infective Ther. 2023;1–12.
- Archbald-Pannone L. How do we best manage clostridioides difficle infections in the elderly? Exp Rev Anti-Infective Ther. 2023. DOI:10.1080/14787210.2023.2158814
- Weiss ZF, Little J, Hammond S. Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now. Exp Rev Anti-Infective Ther. 2023. DOI:10.1080/14787210.2023.2207821
- Bush K. Classification for β-lactamases: historical perspectives. Exp Rev Anti-Infective Ther. 2023. DOI:10.1080/14787210.2023.2194633
- Gabrielli L, Piccirilli G, Petrisli E, et al. What is the impact of SARS-CoV-2 infection during pregnancy on child immunity? Exp Rev Anti-Infective Ther. 2022. DOI:10.1080/14787210.2022.2151436
- Piddock L. An interview with Laura Piddock - by Felicity Poole, commissioning editor. Exp Rev Anti-Infective Ther. 2023. DOI:10.1080/14787210.2023.2168330
- McDonald M, Anker M, Deal C, et al. Proceedings of the first International Conference on women and infectious diseases. February 27-28, 2004. Atlanta, Georgia, USA. Emerg Infect Dis. 2004 Nov;10(11):1963–2036. PMID: 16010728; PMCID: PMC3329007.